Liqun Xia
7PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 29, 2025
Heterogeneous Driving Effects Guide Personalized Tumor Treatments Targeting N6-Methyladenosine.Xudong Mao, Zhehao Xu, Xingbo Yang
|Aug 18, 2023
HIF1A-repressed PUS10 regulates NUDC/Cofilin1 dependent renal cell carcinoma migration by promoting the maturation of miR-194-5p.Wenqin Luo, Zhehao Xu, Huan Wang
|Nov 17, 2022
METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m7G-modified miR-760-dependent manner.Haiyun Xie, Mingchao Wang, Haifeng Yu
|Nov 04, 2021
PIWI-interacting RNA 57125 restrains clear cell renal cell carcinoma metastasis by downregulating CCL3 expression.Lifeng Ding, Ruyue Wang, Wanjiang Xu
|Jun 09, 2021
Role of noncoding RNA in drug resistance of prostate cancer.Lifeng Ding, Ruyue Wang, Danyang Shen
|Jan 25, 2021
Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells.Liqun Xia, Danyang Shen, Youyun Zhang
Pageof 2
